top of page

Use of Radiofrequency Ablation in Benign Thyroid Nodules: A Literature Review and Updates

Use of Radiofrequency Ablation in Benign Thyroid Nodules: A Literature Review and Updates

Use of Radiofrequency Ablation in Benign Thyroid Nodules: A Literature Review and Updates

Citation

Wong, K. P., & Lang, B. H. (2013). Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates. International journal of endocrinology, 2013, 428363. https://doi.org/10.1155/2013/428363

URL

Abstract

Successful thermal ablation using radiofrequency has been reported in various tumors including liver or kidney tumors. Nonsurgical minimally invasive ablative therapy such as radiofrequency ablation (RFA) has been reported to be a safe and efficient treatment option in managing symptomatic cold thyroid nodules or hyperfunctioning thyroid nodules. Pressure and cosmetic symptoms have been shown to be significantly improved both in the short and long terms after RFA. For hyperfunctioning thyroid nodules, RFA is indicated for whom surgery or radioiodine are not indicated or ineffective or for those who refuse surgery or radio-iodine. Improvement of thyroid function with decreased need for antithyroid medications has been reported. Complication rate is relatively low. By reviewing the current literature, we reported its efficacy and complications and compared the efficacy of RFA relative to other ablative options such as ethanol ablation and laser ablation.

Conclusion

Nowadays, available reports of application of RFA in benign thyroid nodules were mainly from two centers. The main weaknesses of using RFA on the thyroid gland are several folds and they include the lack of definitive histology, possibility of incomplete nodule ablation, and surveillance problems for the residual thyroid mass after RFA. However, RFA appears to be an effective nonsurgical option to improve pressure and toxic symptoms in biopsy-proven benign thyroid nodules. Preliminary reports showed satisfactory results in volume reduction, pressure symptoms, and cosmetic symptoms, and these results appear to be sustained in the long term. Therefore, proper selection of patient with benign nodule for RFA and subsequent monitoring were needed.

Key Words

Contact Us

Address

2320 N. Third Street
Phoenix, AZ 85004

Contact

tel: 602-889-2923
fax: 602-889-2925 / 602-889-2926

Opening Hours

Mon - Thurs

7:30 am – 4:30 pm

Friday

7:30 am – 4:00 pm

Closed M-F

12:00 - 1:00 pm Lunch

  • Youtube
  • Facebook
  • Instagram
bottom of page